From attention‐deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non‐medical stimulant use: connecting the dots
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aims To describe the connections among the likelihood of attention deficit/hyperactivity disorder (ADHD), medical and non‐medical methylphenidate and amphetamine use and the diversion of prescribed methylphenidate in the general adolescent population. Design Cross‐sectional self‐reported anonymous data from the 2002 Student Drug Use Survey in the Atlantic Provinces. Setting The Atlantic provinces of Canada. Participants A total of 12 990 students participated. Measurements The outcomes were a positive ADHD screening test, medical and non‐medical use of methylphenidate, medical and non‐medical use of amphetamine and the giving and selling of methylphenidate medication by students with a prescription. The Ontario Child Health Study Hyperactivity Scale was used to screen for ADHD. Findings The prevalence of a positive ADHD screening test was 6% with no significant gender difference. The prevalence of medical and non‐medical methylphenidate use and medical and non‐medical amphetamine use was 2.0%, 6.6%, 1.2% and 8.7%, respectively. A positive ADHD screening test was independently predictive of these four patterns of use. About 26% of students with prescribed methylphenidate gave or sold some of their medication. Students in a class where at least one student had given or sold some of their prescribed pills had a 1.52‐fold increased risk of non‐medical methylphenidate use than their counterparts in classes where no giving or selling had taken place. Conclusions Connections were demonstrated at the population level between ADHD, medical methylphenidate use, the diversion of prescribed methylphenidate and the non‐medical use of methylphenidate. The appropriate assessment and management of ADHD are essential to minimize both the risk of diversion and of substance use associated with unrecognized or untreated ADHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Cohen, P., Cohen, J., Kasen, S., Velez, C. N., Hartmark, C., Johnson, J., Rojas, M., Brook, J., & Streuning, E. L. (1993) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1993.tb01094.x · Cited by 957
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863
Biederman, J., Mick, E., Faraone, S. V., Braaten, E., Doyle, A., Spencer, T., Wilens, T. E., Frazier, E., & Johnson, M. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.36 · Cited by 863
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
The epidemiology of attention‐deficit/hyperactivity disorder (ADHD): A public health view
Rowland, A. S., Lesesne, C. A., & Abramowitz, A. J. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10036 · Cited by 495
Stimulant Treatment for Children: A Community Perspective
ANGOLD, A., ERKANLI, A., EGGER, H. L., & COSTELLO, E. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200008000-00009 · Cited by 353
Cited by
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a56f1 · Cited by 824
Smith, M. E., & Farah, M. J. (2011) · Psychological Bulletin · doi:10.1037/a0023825 · Cited by 440
Rabiner, D. L., Anastopoulos, A. D., Costello, E. J., Hoyle, R. H., McCabe, S. E., & Swartzwelder, H. S. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708320399 · Cited by 238
“Overall, these results are consistent with a recent study showing a positive screening for ADHD was associated with increased likelihood of nonmedical use of prescription stimulants among 12,990 Canadian students in Grades 7, 9, 10, and 12 ( Poulin, 2007 ).”
ResultFaraone, S. V., Rostain, A. L., Montano, C. B., Mason, O., Antshel, K. M., & Newcorn, J. H. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.06.012 · Cited by 225
The Potential for Misuse and Abuse of Medications in ADHD: A Review
Clemow, D. B., & Walker, D. J. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2801 · Cited by 198
Metadata
- Authors
- Poulin, C.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2007-03-02
- Volume
- 102
- Issue
- 5
- Pages
- 740-751
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W1993334327
- Cited by
- 142
- References
- 8
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From attention‐deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non‐medical stimulant use: connecting the dots. https://app.cochat.ai/papers/10.1111/j.1360-0443.2007.01758.x
- The paper
- Poulin, C. (2007). From attention‐deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non‐medical stimulant use: connecting the dots. Addiction. https://doi.org/10.1111/j.1360-0443.2007.01758.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.